| Literature DB >> 24053474 |
Valentina Gatta1, Marco D'Aurora, Paola Lanuti, Laura Pierdomenico, Samantha Sperduti, Giandomenico Palka, Marco Gesi, Marco Marchisio, Sebastiano Miscia, Liborio Stuppia.
Abstract
BACKGROUND: It has been demonstrated that the umbilical cord matrix, represented by the Wharton's Jelly (WJ), contains a great number of mesenchymal stem cells (MSCs), characterized by the expression of specific MSCs markers, shared by both human and animal models. The easy access to massive WJ amount makes it an attractive source of MSCs for cell-based therapies. However, as in other stem cell models, a deeper investigation of WJ-derived MSCs (WJ-MSCs) biological properties, probably modulated by their prolonged expansion and fast growth abilities, is required before their use in clinical settings. In this context, in order to analyze specific gene expression modifications occurring in WJ-MSCs, along with their culture prolongation, we investigated the transcriptomic profiles of WJ-MSCs after 4 and 12 passages of in vitro expansion by microarray analysis.Entities:
Mesh:
Year: 2013 PMID: 24053474 PMCID: PMC3849041 DOI: 10.1186/1471-2164-14-635
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Phenotype and markers expression levels in WJ-MSC at 4and 12passage
| + | 11.6 ± 0.8 | 7.7 ± 0.8 | ||
| - | 1.3 ± 0.1 | 1.1 ± 0.1 | 0.222 | |
| +++ | 154.6 ± 7.3 | 141.9 ± 2.4 | 0.036 | |
| - | 1.3 ± 0.1 | 1.1 ± 0.1 | 0.210 | |
| +++ | 173.8 ± 20.1 | 82.0 ± 8.7 | ||
| - | 1.1 ± 0.2 | 1.2 ± 0.2 | 0.308 | |
| ++ | 49.5 ± 2.7 | 19.9 ± 1.1 | ||
| ++ | 78.4 ± 2.6 | 81.0 ± 3.2 | 0.226 | |
| + | 8.7 ± 0.7 | 7.9 ± 0.5 | 0.218 | |
| - | 1.8 ± 0.2 | 1.5 ± 0.2 | 0.152 | |
| - | 1.5 ± 0.1 | 1.2 ± 0.1 | 0.094 | |
| - | 1.2 ± 0.1 | 1.3 ± 0.2 | 0.320 | |
| + | 10.5 ± 0.6 | 11.3 ± 0.6 | 0.230 | |
| + | 14.4 ± 0.9 | 6.8 ± 1.2 | 0.014 | |
| - | 1. 1 ± 0.1 | 1.1 ± 0.1 | 0.420 | |
| + | 24.0 ± 0.4 | 24.9 ± 0.6 | 0.023 | |
| - | 1.3 ±0.1 | 1.1 ± 0.1 | 0.341 | |
– negative expression; + moderate expression; ++ positive; +++ high expression; MFI Ratio is the average of five different biological samples ± standard deviation; Bold values represent MFI Ratio With p < 0.01; Cut-off positivity MFI Ratio > 2.
Figure 1WJCs characterization. Light microscopic micrographs of WJ-MSCs in monolayer at the 4th(A) and the 12th(B) culture passages. In monolayer culture, cells assumed a polymorphic, fibroblast-like morphology, which was maintained throughout the time of culture (scale bar 40 μm). Growth characterization of WJ-MSCs during the in vitro expansion (4th and 12th passage) measured by cell count (C) and by the BrdU incorporation assay, allowing the doubling time evaluation (D). The ability of WJ-MSCs to differentiate into the adipogenic lineage at the 4th(E) and the 12th(F) culture passages was evidenced by the intracellular accumulation of neutral lipid vacuoles (red oil staining) (scale bar 20 μm). Osteogenic differentiation at the 4th(G) and the 12th(H) culture passages was indicated by the increase in alkaline phosphatase reaction (scale bar 80 μm). Light microscopic micrographs A, B, E, F, G and H are representative of five separate biological samples.
Figure 2Hierarchical clustering analysis. The cluster analysis shows the presence of two different clusters composed respectively by 157 up-regulated transcripts (cluster 1) and 440 down-regulated genes (cluster 2). In the figure, all the relevant genes are grouped according to their expression values, shown as log ratios. Each row corresponds to one gene, each column to the different 6 microarray experiments. The quantitative changes in gene expression across all the samples are represented in different colors: red indicates over-expressed genes, and green indicates down-regulated genes. Black bars indicate no changes in gene expression. Missing data points are represented as gray bars. The top labels indicate the different experiments.
Figure 3IPA functional analysis and first top network associated with the Cluster 1. (A) Bar chart shows key function associated with genes found to be up-regulated (cluster 1) in WJ-MSCs after 12 passages of their in vitro expansion, as compared to WJ-MSCs at the 4th passage. (B) Network cluster 1: in grey are represented the genes up-regulated in WJ-MSCs after 12 passages of their in vitro expansion, as compared to WJ-MSCs at the 4th passage. Transcripts not modulated along with the different passages are represented in white. Arrows indicate that a molecule acts on another molecule, while lines indicate a bind between two molecules.
Figure 4IPA functional analysis and first top network associated with the Cluster 2. (A) Bar chart shows key function associated with genes found to be down-regulated (cluster 2) at the 12th passage of WJ-MSCs as compared to cells at the 4th passage. (B) Network cluster 2: in gray are represented the down-regulated genes at the 12th passage of WJ-MSCs in vitro expanded, as compared to the same cells at the 4th passage. Transcripts not modulated along with the different passages are represented in white. Arrows indicate that a molecule acts on another molecule, while lines indicate a bind between two molecules.
Up-regulated gene functions in cell cultures at 12passage as compared to cells at 4passage
| IL1 NODE | IL1 | Pro-inflammatory cytokine involved in host defense | Activation of NF-kappaB; Induction of acute and chronic inflammation | [ |
| IL1B | Cytokine activated by Caspase 1 | Cell proliferation; Cell differentiation; Apoptosis | [ | |
| IL1R1 | Cytokine receptor 1 | Immune and inflammatory response | [ | |
| S100A13 | Calcium binding protein induced by inflammatory stress | Cell cycle progression; Cellular differentiation | [ | |
| TWIST2 | MSCs marker | Negative regulator of IL1B; Cell lineage determination; Cellular differentiation | [ | |
| AKT NODE | AKT | Protein kinase B | Cellular growth; Mitosis; Cellular differentiation | [ |
| RAC2 | Member of Rho GTPase family | Proliferation; Cellular differentiation; Cytoskeletal organization; Cellular adhesion; Membrane trafficking, Transcriptional regulation | [ | |
| PTPRF | LAR protein tyrosine phosphatase sigma family | Neuronal differentiation; Cellular development | [ | |
| Transcription regulators | CREBBP | CREB binding protein | Histone acetyltransferase activity; Transcriptional regulation | [ |
| PARP1 | Poly (ADP-ribose) polymerase | Cellular proliferation; Cellular differentiation | [ | |
| HNRNPAB | Ribonucleoprotein associated with pre-mRNAs | RNA processing and trafficking; Cellular differentiation | [ | |
| NONO | RNA-binding protein | Transcriptional regulation; RNA splicing; RNA retention in nucleus | [ | |
| Cytoskeleton organization | ACTR3 | Actin-related protein | Neuronal differentiation | [ |
| NISCH | Nischarin | Negative role in cell migration | [ | |
| Neural markers | EPHA4 | Ephrin recepotor of protein-tyrosine kinase family | Nervous system development | [ |
| MT2A | Melatonin recepror 2 | Expressed in neural progenitor | [ | |
| CDH2 | Cadherin | Cellular differentiation via RAC | [ | |
| | ERRFI1 | Cytoplasmic protein | Induced by cellular stress; Cell signalling | [ |
| | RNF7 | Ring finger protein | Part of protein degradation machinery; Antiapoptotic activity via JUN | [ |
| LYN | v-yes-1 Yamaguchi sarcoma viral related oncogene | Tyrosine kinase activity; Cellular proliferation | [ |
Down-regulated gene functions in cell cultures at 12passage as compared to cells at 4passage
| TP53 NODE | TP53 | Major tumor protein suppressor | Cell cycle; Apoptosis; Senescence | [ |
| UBE2D3 | Member of E2 ubiquitin conjugating enzyme family | Protein degradation machinery | [ | |
| MAP2K3 | Protein kinase activated by environmental stress | Gene expression regulation; Mitosis; Cellular differentiation; Cellular proliferation; Apoptosis; Senescence | [ | |
| ZHX1 | Zing finger and homeoboxes gene family | Maintenance of TP53 gene silencing | [ | |
| XPO1 | Exportin 1 | Protein trafficking; Localization of cyclin b; Localization of MPAK; Nuclear export of TP53 | [ | |
| PIN1 | Phosphorylation-dependent prolyne isomerase | Cellular differentiation; Cellular proliferation; Immune response; Mitosis | [ | |
| CDC27 | Component of anaphase promoting complex | Mitosis; Ubiquitination | [ | |
| ANAPC2 | Anaphase promoting complex | Cell cycle control; Ubiquitination | [ | |
| Cell cycle regulation and differentiation | TYMS | Thymidylate syntase | DNA replication and repair; Mitosis | [ |
| FGFR3 | Fibroblast growth factor receptor 3 | Mitosis; MSCs differentiation | [ | |
| NCAPD2 | Subunit of condensin I | Mitosis; Proliferation | [ | |
| MITF | Transcription factor | Cell cycle regulation; Gene expression; Differentiation | [ | |
| Oxidative stress response | RPS3 | Ribosomal protein (40s subunit) | DNA damage repair; Kinase activity on NFkB complex | [ |
| NFE2L2 | Human basic leucine zipper transcription factor | Oxidative stress response | [ | |
| HSP1 | Heat-shock protein 1 | Protein folding | [ | |
| NFkB signalling | IKBKG | Regulatory subunit of IKK complex | NFkB activation | [ |
| MYL5 | Myosin light chain | NFkB activation | [ | |
| Apoptosis | SLC6A4 | Membrane serotonin transporter | Apoptosis | [ |
| Histonic modification | HAT1 | Histone acetyltransferase B | Histone acetylation; Aging; Cellular differentiation | [ |
| HIST1H3C | Member of Histone H3 family | Transcriptional regulation; Cellular differentiation | [ |
Figure 5Validation microarray gene expression data by qRT-PCR. Analysis of the selected genes IL1B, CREBBP, LYN, P53, HSPE1, HIST1H3C was carried on the RNA obtained by 4th and 12th passage of WJ-MSCs. Data are the means ± SD of three independent experiments in triplicate (*P < 0.01, Student’s t-test).